首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Psoriasis-targets and therapy

缩写:

ISSN:N/A

e-ISSN:2230-326X

IF/分区:5.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引177
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Thomas Damsin,Gilles Absil,Florence Libon et al. Thomas Damsin et al.
Background: Biological therapies, including TNF-alpha, IL12/23, IL17 and IL23 antagonists, adequately control a very high number of patients with moderate-to-severe psoriasis with an excellent long-term safety profile. Ho...
Lu Wei,Buxin Zhang,Yuanhui Tu et al. Lu Wei et al.
Psoriasis is a chronic inflammatory disease with a complex pathogenesis. Hyperplasia of glycolytic-dependent epidermal keratinocytes (KCs) is a new hallmark of psoriasis pathogenesis. Meanwhile, immune cells undergo metabolic reprogramming ...
Rui Mao,Tongtong Zhang,Ziye Yang et al. Rui Mao et al.
Background: Current pharmacological treatments for psoriasis are generally non-specific and have significant limitations, particularly in the realm of targeted biologic therapies. There is an urgent need to identify and d...
Liangzhe Wang,Shuaijun Zou,Yuanjie Zhu Liangzhe Wang
Acrodermatitis enteropathica (AE) can be caused by inherited or acquired zinc deficiency, among which site-specific skin lesions or even psoriasiform skin manifestations are present. Few cases exist in the literature involving the diagnosis...
Vardhaman Patel,Sang Hee Park,Yichen Zhong et al. Vardhaman Patel et al.
Purpose: This real-world study investigated the impact of patient-reported disease burden and health-related quality of life (HRQoL) on switching from systemic nonbiologic to biologic therapy in patients with plaque psori...
Chao Wu,Chunxia He,Haimeng Wang et al. Chao Wu et al.
Purpose: This prospective observational study investigated whether interleukin (IL)-17A inhibitors could reduce serum uric acid (SUA) levels in psoriatic patients with hyperuricemia. It also explored the risk factors for ...
Kathryn Haran,Chandler E Johnson,Payton Smith et al. Kathryn Haran et al.
Psoriasis is an immune-mediated skin disease known to be associated with a higher risk of cardiometabolic comorbidities such as hypertension, myocardial infarction, and stroke. GLP-1 receptor agonists (GLP-1RAs) are medications approved to ...
Federica Dall&#x;Oglio,Anna Elisa Verzì,Giulia Guglielmi et al. Federica Dall&#x;Oglio et al.
Purpose: Psoriasis affecting sensitive areas and folds represents a therapeutic challenging as the skin in these areas may be more prone to local pharmacological side effects. The aim of this prospective, randomized, open...
Vito Di Lernia,Cristina Bertoli Vito Di Lernia
Psoriasis is a chronic, immunologically mediated disease of multifactorial origin, with genes playing a key role and environmental factors, such as infections, often triggering its onset or exacerbation. While acute streptococcal infections...
Patrícia Medeiros Gusmão Acioly,Mara Diane Lisboa Tavares Mazzillo,Carla Jorge Machado et al. Patrícia Medeiros Gusmão Acioly et al.
Background: There is a growing body of evidence suggesting the association between psoriasis (PsO) and psoriatic arthritis (PsA) separately with metabolic syndrome (MS) in different populations. The literature is relative...